ClinicalTrials.Veeva

Menu

Deep Learning Signature for Predicting Aggressive Histological Pattern in Resected Non-small Cell Lung Cancer

S

Shanghai Pulmonary Hospital, Shanghai, China

Status

Enrolling

Conditions

Spread Through Air Space
Visceral Pleural Invasion
Non-small Cell Lung Cancer
Lymphovascular Invasion

Treatments

Diagnostic Test: PET/CT-based Deep Learning Signature

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to evaluate the performance of a PET/ CT-based deep learning signature for predicting aggressive histological pattern in resected non-small cell lung cancer based on a multicenter prospective cohort.

Enrollment

1,500 estimated patients

Sex

All

Ages

20 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

(1) Participants scheduled for surgery for radiological finding of pulmonary lesions from the preoperative thin-section CT scans; (2) Pathological confirmation of primary NSCLC; (3) Age ranging from 20-75 years; (4) Obtained written informed consent.

Exclusion criteria

(1) Multiple lung lesions; (2) Poor quality of PET-CT images; (3) Participants with incomplete clinical information; (4) Participants who have received neoadjuvant therapy.

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems